Neurology
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}

      • Manage-PD

      About aPD
      Identifying aPD
      Manage PD
      DAT Selection

      Introducing the
      MANAGE-PD tool

      MANAGE-PD is a screening tool designed to support healthcare professionals in the identification of patients with advanced Parkinson’s disease (aPD) who may be uncontrolled on their current treatment regimen.1

      decorative

      Understanding MANAGE-PD with Prof. Angelo Antonini

      Leading international neurologist Prof. Angelo Antonini from the Parkinson’s and Movement Disorders Unit at the Department of Neuroscience, University of Padua, Italy, discusses the development and validation of the Manage-PD tool, and how it helps to address the unmet needs in current aPD management. (19:30 mins)

      Skip to your preferred section

      MANAGE-PD builds on the Delphi consensus criteria* to create a clinically useful tool1

      decorative

      DELPHI STUDY

      Consensus developed with leading experts in EU2

      decorative

      WEB SURVEY

      MDSs from multiple countries identified key indicators of inadequate symptom control on orals3

      decorative

      COGNITIVE INTERVIEWS

      “Deep-dive” consultation with 5 MDSs to enhance the tool4

      *Taking oral levodopa ≥ 5 times daily, ≥ 2 hours of OFF time/day, presence of unpredictable fluctuations of motor symptoms, presence of troublesome dyskinesia, and limitations in ≥ 1 activity of daily living.2

      MANAGE-PD allows you to:

      Identify patients inadequately controlled on oral medications.

      Determine which patients with aPD may be adequately controlled on their current treatment regimen or may require changes to their treatment regimen (including evaluation for device-aided therapy).

      Start using MANAGE-PD
      decorative
      Request more Information
      Request more Information

      All content is intended only for informational use by licensed healthcare professionals and is not offered as or intended to be medical advice for any particular patient. This information is not intended for patients.

      Only a healthcare professional exercising independent clinical judgment can make decisions regarding appropriate patient care and treatment options considering the unique characteristics of each patient.

      MANAGE-PD is a screening tool intended to be used by healthcare professionals (HCPs). This tool is aiming to support HCP’s decision-making for the timely management of Parkinson’s disease symptoms based on comprehensive evaluation of frequency and severity of the motor, non-motor and functional symptoms.

      This questionnaire consists of two parts: Section 1 and Section 2. Symptoms should be assessed based on the previous 1 month. This tool does not give guidance concerning the type of device-aided therapy, but gives an indication that this type of therapy can be considered. Use of the AbbVie name, its logos, their trademarks, trade names or trade dress is prohibited without the prior written authorisation of AbbVie, except to identify the product or services of AbbVie. The Parkinson’s Foundation logo is the sole property of the Parkinson’s Foundation. Any use of the Parkinson’s Foundation name or logo without Foundation permission is prohibited.

      Manage-PD is a collaborative research and development effort between AbbVie Inc. Medical Affairs and Health Economics and Outcomes, the Parkinson’s Foundation and an international panel of movement disorder specialists.

      Abbreviation: MDS; Movement disorder specialist. aPD; advanced Parkinson’s disease.
      References: 1. Antonini A, et al. Parkinsonism Relat Disord 2021 Nov;92:59-66. 2. Antonini A et al. Curr Med Res Opin 2018;34(12):2063–2073. 3. Antonini A et al. (2019) 23rd Annual International Congress of Parkinson’s Disease and Movement Disorders. Nice, France. Abstract 2142. 4. Antonini A et al. 2019. Poster presented at AAN, Philadelphia, PA. May 4–10, 2019.

      AU-NEUP-230059. June 2024.